Protein Tyrosine Kinases (PTK) in Multiple Myeloma

NCT00165347 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: PTK787/ZK222584

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]